SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is currently seeing significant community interest driven by recent strength in custom AI silicon and networking partnerships, even as some analysts adjust their high-conviction ratings. Investors are actively debating the sustainability of current AI infrastructure spending versus the stock's long-term growth potential ahead of upcoming earnings.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is facing intense volatility following a mixed market reaction to its latest earnings report, with investors scrutinizing the durability of AI-driven capital expenditure. While management remains optimistic about long-term growth, the community is currently debating whether the sell-off represents a buying opportunity or a deeper correction for the semiconductor equipment sector.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing high volatility as investors weigh strong demand for its AI-focused optical transceivers against capacity constraints and concerns over potential supply chain risks. The community is actively debating the stock's long-term growth potential versus short-term valuation concerns, with many traders focusing on aggressive price swings and the stock's role in the broader photonics sector.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is experiencing significant volatility driven by a combination of an analyst downgrade and leadership changes, while bullish investors continue to highlight the company's impressive customer growth and recent AI-focused product innovations. Community sentiment remains deeply divided, with some traders expressing frustration over recent price declines and management turnover, while others are aggressively buying the dip in anticipation of a potential US market entry and long-term ecosystem expansion.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

Investors are closely monitoring QXO as it navigates significant post-merger integration and volatility, with the community actively debating whether the current price represents a deep value entry point or a result of ongoing dilution and structural challenges. While some shareholders remain bullish on Brad Jacobs' long-term acquisition strategy, frustration is mounting over the lack of official earnings communication and the stock's persistent inability to hold gains.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Boost Run is experiencing heightened community interest and price volatility following its recent earnings report, which highlighted significant revenue growth and a growing backlog of contracted deals. While investors remain enthusiastic about the company's position as an NVIDIA Preferred Cloud Partner in the AI infrastructure space, the stock is also seeing active debate regarding potential share dilution from upcoming warrant redemption deadlines.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing significant volatility and downward pressure as the community reacts to an accelerated lockup expiration, which has sparked intense debate over the fund's fair value relative to its NAV. Traders are actively clashing over whether the current price represents a buying opportunity or a 'trap' given the fund's exposure to high-profile private AI companies like Anthropic and OpenAI versus the risk of a flood of selling.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

LightPath Technologies is trending as investors focus on its BlackDiamond material as a strategic domestic alternative to Chinese-sourced germanium, especially following government initiatives to secure defense supply chains. The community is actively discussing the stock's potential re-rating due to its integration into mission-critical counter-UAS and missile defense platforms.

Investment Managers Series Trust II - Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF

The Tradr 2X Short SNDK Daily ETF (SNDQ) is experiencing heightened volatility following SanDisk's cancellation of a major semiconductor plant expansion in Michigan, prompting intense community debate over potential delisting risks and the impact of sector-wide patent disputes. Investors are actively split, with some capitalizing on the sharp price swings through aggressive day trading and scalp positions, while others warn of the significant volatility decay inherent in this leveraged ETF.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as retail investors rally behind a transformational patent settlement with Samsung and a newly launched ITC infringement action against industry giants. The community is heavily focused on the potential for a massive short squeeze, viewing the stock as a long-term play against major sector players who they believe will be forced into lucrative licensing deals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IONS Investors Have Opportunity to Join Ionis Pharmaceuticals, Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ionis Pharmaceuticals, Inc. (Ionis or the Company) (NASDAQ: IONS) for violations of the securities laws. INVESTIGATION DETAILS: The investigation...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS PR Newswire NEW YORK, Aug. 6, 2026 NEW YORK, Aug. 6, 2026...

Monday 8/3 Insider Buying Report: IONS, VFC

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

On Friday, Ionis Pharmaceuticals' Director, Michael R. Hayden, made a $1.06M buy of...

IONS Beats Q2 Earnings & Sales Estimates, Reiterates '26 Outlook

Ionis beats Q2 revenues and earnings estimates as commercial growth offsets tough comparisons, while reaffirming its 2026 outlook.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS PR Newswire NEW YORK, July 30, 2026 NEW YORK, July 30, 2026...

Biogen's Q2 Earnings Beat, New Drugs Drive Sales, 2026 Guidance Raised

Biogen tops Q2 earnings and revenue estimates as growth drugs fuel sales, offset MS declines, and support a higher 2026 revenue and EPS outlook.

Ionis Pharmaceuticals (IONS) Reports Q2 Loss, Tops Revenue Estimates

Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of +51.69% and +40.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Ionis announces Dr. Frank Bennett, chief scientific officer, to retire

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that Frank Bennett, Ph.D., executive vice president and chief scientific officer, will retire effective February 2027.As a founding scientist, Frank has been instrumental in shaping Ionis and advancing the entire field of RNA-targeted...

Ionis reports second quarter 2026 financial results and highlights progress on key programs

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the Company) today reported financial results and provided key updates for the second quarter ended June 30, 2026. With the approval of TRYNGOLZA in late June, Ionis is bringing the first and only treatment to reduce triglycerides and acute pancreatitis...

Ionis Pharmaceuticals, Inc. (IONS) Faces Investor Scrutiny After Surprise Trial Failure Drives Stock Down 23% - HBSS

Ionis Pharmaceuticals, Inc. (IONS) Faces Investor Scrutiny After Surprise Trial Failure Drives Stock Down 23% - HBSS Ionis Pharmaceuticals, Inc. (IONS) Faces Investor Scrutiny After Surprise Trial Failure Drives Stock Down 23% - HBSS PR Newswire SAN FRANCISCO, July 23, 2026 SAN FRANCISCO, July 23...

$IONS Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.69 down -188.46% YoY
• Reported revenue of $268M down -40.71% YoY
• Ionis Pharmaceuticals remains on track to achieve its 2026 financial guidance, including full-year product sales targets for TRYNGOLZA and DAWNZERA, while maintaining its goal of cashflow breakeven in 2028.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Ionis Pharmaceuticals Inc

BBIO Stock Surges 16% As AstraZeneca-Ionis Heart Drug Trial Misses Goal — BofA Calls Failure ‘A Big Surprise’

Equity

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

IONSIonis Pharmaceuticals Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest IONS News